Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023215 · ClinicalTrials.gov registry record · NA
Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03023215: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT03023215 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03023215, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The goal of this behavioral research study is to learn if taking part in guided relaxation programs helps to reduce anxiety and pain during stereotactic breast biopsy. The study will also examine whether the guided relaxation programs change brain activity, heart rate, and blood pressure.
Primary Outcome
Trial considered successful if over 50% of eligible patients participate and at least 80% of the consented patients complete the sessions and all the measures for the study.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Electroencephalogram
- PROCEDURE Meditation
- PROCEDURE Heart Rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2012-10-26 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
What the finished NCT03023215 record still lists
NCT03023215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Questionnaires is the first listed.
NCT03023215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03023215 about?
NCT03023215 is a clinical study titled "Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy". The goal of this behavioral research study is to learn if taking part in guided relaxation programs helps to reduce anxiety and pain during stereotactic breast biopsy. The study will also examine whether the guided relaxation programs change brain activity, heart rate, and blood pressure.
What is the current status of trial NCT03023215?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2012-10-26. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT03023215?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Electroencephalogram (PROCEDURE), Meditation (PROCEDURE), Heart Rate (PROCEDURE).
Who is sponsoring clinical trial NCT03023215?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03023215's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI